Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
Gabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 339
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Daniel Frank, James E. Vince
Cell Death and Differentiation (2018) Vol. 26, Iss. 1, pp. 99-114
Open Access | Times Cited: 870
The Hallmarks of Ferroptosis
Scott J. Dixon, Brent R. Stockwell
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 35-54
Closed Access | Times Cited: 496
Modes of Regulated Cell Death in Cancer
Elle Koren, Yaron Fuchs
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 245-265
Open Access | Times Cited: 288
Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer
Alessandro Annibaldi, Pascal Meier
Trends in Molecular Medicine (2017) Vol. 24, Iss. 1, pp. 49-65
Closed Access | Times Cited: 245
Cell death pathways: intricate connections and disease implications
Matthias Kist, Domagoj Vucic
The EMBO Journal (2021) Vol. 40, Iss. 5
Open Access | Times Cited: 237
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 211
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison, Zachary Goodman, Abdul Jabbar, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 5, pp. 816-827
Closed Access | Times Cited: 206
Necroptosis and Cancer
Ayaz Najafov, Hongbo Chen, Junying Yuan
Trends in cancer (2017) Vol. 3, Iss. 4, pp. 294-301
Open Access | Times Cited: 181
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis
Emma J. Petrie, Jarrod J. Sandow, Annette V. Jacobsen, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 171
Lytic cell death in metabolic liver disease
Jérémie Gautheron, Gregory J. Gores, Cecília M. P. Rodrigues
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 394-408
Open Access | Times Cited: 168
Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
Yadong Xie, Yifan Zhao, Lei Shi, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 2111-2128
Open Access | Times Cited: 163
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci, Manon Bourinet, Pierre Leclère, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 148
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum, Nicole A. Wilski, Andrew E. Aplin
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 266-281
Open Access | Times Cited: 131
A long way to go: caspase inhibitors in clinical use
Shanel Dhani, Yun Zhao, Boris Zhivotovsky
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 118
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 105
Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway
Daniel S. Simpson, Jiyi Pang, Ashley Weir, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 423-441.e9
Open Access | Times Cited: 97
Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases
Kate E. Lawlor, James M. Murphy, James E. Vince
Immunity (2024) Vol. 57, Iss. 3, pp. 429-445
Closed Access | Times Cited: 21
RIPK3 signaling and its role in regulated cell death and diseases
Yaqi Zhou, Yaxuan Xiang, S. Liu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
Kelby W. Wegner, Danish Saleh, Alexei Degterev
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 3, pp. 202-225
Open Access | Times Cited: 152
Cysteine proteases in protozoan parasites
Jair L. Siqueira-Neto, Anjan Debnath, Laura‐Isobel McCall, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 8, pp. e0006512-e0006512
Open Access | Times Cited: 146
Multiple roles of caspase-8 in cell death, inflammation, and innate immunity
Pontus Ørning, Egil Lien
Journal of Leukocyte Biology (2020) Vol. 109, Iss. 1, pp. 121-141
Open Access | Times Cited: 132
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han, Zhida Liu, Yunjia Zhang, et al.
Nature Immunology (2020) Vol. 21, Iss. 5, pp. 546-554
Closed Access | Times Cited: 119
Future Therapeutic Directions for Smac-Mimetics
Emma Morrish, Gabriela Brumatti, John Silke
Cells (2020) Vol. 9, Iss. 2, pp. 406-406
Open Access | Times Cited: 117
Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease
Holly Anderton, Ian P. Wicks, John Silke
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 9, pp. 496-513
Closed Access | Times Cited: 113
The role of necroptosis in cancer: A double-edged sword?
Xia Qin, Dan Ma, Yexiong Tan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 259-266
Closed Access | Times Cited: 111
Page 1 - Next Page

Scroll to top